nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—PTGS1—breast cancer	0.12	0.364	CbGaD
Eletriptan—CYP2D6—breast cancer	0.0814	0.247	CbGaD
Eletriptan—CYP3A4—breast cancer	0.0699	0.212	CbGaD
Eletriptan—CYP2A6—Letrozole—breast cancer	0.0592	0.142	CbGbCtD
Eletriptan—ABCB1—breast cancer	0.0582	0.177	CbGaD
Eletriptan—HTR2B—Raloxifene—breast cancer	0.043	0.103	CbGbCtD
Eletriptan—CYP2C9—Anastrozole—breast cancer	0.0182	0.0435	CbGbCtD
Eletriptan—CYP2A6—Tamoxifen—breast cancer	0.0176	0.0423	CbGbCtD
Eletriptan—ABCB1—Toremifene—breast cancer	0.0161	0.0386	CbGbCtD
Eletriptan—CYP2C19—Lapatinib—breast cancer	0.0146	0.0349	CbGbCtD
Eletriptan—CYP3A4—Exemestane—breast cancer	0.0139	0.0334	CbGbCtD
Eletriptan—CYP2C9—Idarubicin—breast cancer	0.0138	0.033	CbGbCtD
Eletriptan—CYP2A6—Fluorouracil—breast cancer	0.013	0.0312	CbGbCtD
Eletriptan—CYP2D6—Idarubicin—breast cancer	0.0126	0.0302	CbGbCtD
Eletriptan—CYP3A4—Letrozole—breast cancer	0.0118	0.0284	CbGbCtD
Eletriptan—ABCB1—Lapatinib—breast cancer	0.0118	0.0282	CbGbCtD
Eletriptan—CYP3A4—Anastrozole—breast cancer	0.0106	0.0253	CbGbCtD
Eletriptan—CYP3A4—Toremifene—breast cancer	0.00966	0.0231	CbGbCtD
Eletriptan—CYP3A4—Fulvestrant—breast cancer	0.00898	0.0215	CbGbCtD
Eletriptan—CYP3A4—Thiotepa—breast cancer	0.008	0.0192	CbGbCtD
Eletriptan—CYP2C9—Capecitabine—breast cancer	0.00754	0.0181	CbGbCtD
Eletriptan—CYP3A4—Ixabepilone—breast cancer	0.00732	0.0175	CbGbCtD
Eletriptan—CYP2C19—Tamoxifen—breast cancer	0.0073	0.0175	CbGbCtD
Eletriptan—CYP3A4—Lapatinib—breast cancer	0.00704	0.0169	CbGbCtD
Eletriptan—ABCB1—Vinorelbine—breast cancer	0.00652	0.0156	CbGbCtD
Eletriptan—CYP2D6—Vinorelbine—breast cancer	0.00614	0.0147	CbGbCtD
Eletriptan—CYP2C9—Tamoxifen—breast cancer	0.00607	0.0145	CbGbCtD
Eletriptan—ABCB1—Tamoxifen—breast cancer	0.00589	0.0141	CbGbCtD
Eletriptan—ABCB1—Mitoxantrone—breast cancer	0.00574	0.0138	CbGbCtD
Eletriptan—CYP2D6—Tamoxifen—breast cancer	0.00555	0.0133	CbGbCtD
Eletriptan—CYP3A4—Raloxifene—breast cancer	0.00534	0.0128	CbGbCtD
Eletriptan—ABCB1—Gemcitabine—breast cancer	0.00507	0.0122	CbGbCtD
Eletriptan—CYP2C9—Paclitaxel—breast cancer	0.00472	0.0113	CbGbCtD
Eletriptan—ABCB1—Paclitaxel—breast cancer	0.00458	0.011	CbGbCtD
Eletriptan—ABCB1—Irinotecan—breast cancer	0.00452	0.0108	CbGbCtD
Eletriptan—CYP2C9—Fluorouracil—breast cancer	0.00447	0.0107	CbGbCtD
Eletriptan—ABCB1—Vinblastine—breast cancer	0.00402	0.00963	CbGbCtD
Eletriptan—CYP3A4—Vinorelbine—breast cancer	0.00391	0.00937	CbGbCtD
Eletriptan—CYP2D6—Vinblastine—breast cancer	0.00379	0.00908	CbGbCtD
Eletriptan—CYP3A4—Tamoxifen—breast cancer	0.00353	0.00846	CbGbCtD
Eletriptan—CYP3A4—Mitoxantrone—breast cancer	0.00344	0.00825	CbGbCtD
Eletriptan—ABCB1—Docetaxel—breast cancer	0.00331	0.00794	CbGbCtD
Eletriptan—CYP3A4—Paclitaxel—breast cancer	0.00275	0.00658	CbGbCtD
Eletriptan—CYP3A4—Irinotecan—breast cancer	0.00271	0.00649	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—breast cancer	0.00247	0.00592	CbGbCtD
Eletriptan—CYP3A4—Vinblastine—breast cancer	0.00241	0.00577	CbGbCtD
Eletriptan—ABCB1—Methotrexate—breast cancer	0.00239	0.00573	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—breast cancer	0.00233	0.00558	CbGbCtD
Eletriptan—CYP3A4—Docetaxel—breast cancer	0.00198	0.00476	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—breast cancer	0.00148	0.00355	CbGbCtD
Eletriptan—Sumatriptan—SLCO1B1—breast cancer	0.000696	0.301	CrCbGaD
Eletriptan—Sumatriptan—ABCG2—breast cancer	0.000303	0.131	CrCbGaD
Eletriptan—Encainide—CYP2D6—breast cancer	0.000284	0.123	CrCbGaD
Eletriptan—HTR1E—female gonad—breast cancer	0.000214	0.0573	CbGeAlD
Eletriptan—Clemastine—CYP2D6—breast cancer	0.000211	0.0916	CrCbGaD
Eletriptan—Almotriptan—CYP2D6—breast cancer	0.000183	0.0794	CrCbGaD
Eletriptan—Clemastine—CYP3A4—breast cancer	0.000181	0.0786	CrCbGaD
Eletriptan—Almotriptan—CYP3A4—breast cancer	0.000157	0.0681	CrCbGaD
Eletriptan—CYP2C9—mammary gland—breast cancer	0.000157	0.0421	CbGeAlD
Eletriptan—CYP2A6—adipose tissue—breast cancer	0.000142	0.038	CbGeAlD
Eletriptan—HTR2B—skin of body—breast cancer	0.000128	0.0344	CbGeAlD
Eletriptan—Sumatriptan—ABCB1—breast cancer	0.000126	0.0546	CrCbGaD
Eletriptan—HTR2B—endometrium—breast cancer	0.000121	0.0324	CbGeAlD
Eletriptan—PTGS1—nipple—breast cancer	0.000119	0.0318	CbGeAlD
Eletriptan—HTR7—epithelium—breast cancer	0.000115	0.0309	CbGeAlD
Eletriptan—HTR2B—uterus—breast cancer	0.000111	0.0299	CbGeAlD
Eletriptan—HTR1B—female reproductive system—breast cancer	0.000111	0.0298	CbGeAlD
Eletriptan—HTR2B—adipose tissue—breast cancer	0.000109	0.0292	CbGeAlD
Eletriptan—HTR1D—female reproductive system—breast cancer	0.000108	0.0288	CbGeAlD
Eletriptan—HTR2B—female reproductive system—breast cancer	0.0001	0.0268	CbGeAlD
Eletriptan—HTR2B—adrenal gland—breast cancer	9.77e-05	0.0262	CbGeAlD
Eletriptan—Mesoridazine—CYP2D6—breast cancer	9.5e-05	0.0412	CrCbGaD
Eletriptan—HTR1B—endocrine gland—breast cancer	9.41e-05	0.0252	CbGeAlD
Eletriptan—HTR1A—adrenal gland—breast cancer	8.76e-05	0.0235	CbGeAlD
Eletriptan—HTR7—female reproductive system—breast cancer	8.58e-05	0.023	CbGeAlD
Eletriptan—HTR7—adrenal gland—breast cancer	8.37e-05	0.0224	CbGeAlD
Eletriptan—PTGS1—epithelium—breast cancer	7.98e-05	0.0214	CbGeAlD
Eletriptan—HTR1A—endocrine gland—breast cancer	7.59e-05	0.0203	CbGeAlD
Eletriptan—PTGS1—skin of body—breast cancer	7.59e-05	0.0203	CbGeAlD
Eletriptan—HTR7—endocrine gland—breast cancer	7.26e-05	0.0194	CbGeAlD
Eletriptan—Thioridazine—CYP2D6—breast cancer	7.17e-05	0.0311	CrCbGaD
Eletriptan—PTGS1—endometrium—breast cancer	7.16e-05	0.0192	CbGeAlD
Eletriptan—CYP2C19—endocrine gland—breast cancer	7.09e-05	0.019	CbGeAlD
Eletriptan—PTGS1—uterus—breast cancer	6.59e-05	0.0177	CbGeAlD
Eletriptan—CYP2C9—female reproductive system—breast cancer	6.49e-05	0.0174	CbGeAlD
Eletriptan—PTGS1—pituitary gland—breast cancer	6.47e-05	0.0174	CbGeAlD
Eletriptan—PTGS1—adipose tissue—breast cancer	6.45e-05	0.0173	CbGeAlD
Eletriptan—PTGS1—female reproductive system—breast cancer	5.93e-05	0.0159	CbGeAlD
Eletriptan—HTR2B—lymph node—breast cancer	5.86e-05	0.0157	CbGeAlD
Eletriptan—PTGS1—adrenal gland—breast cancer	5.78e-05	0.0155	CbGeAlD
Eletriptan—ABCB1—embryo—breast cancer	5.78e-05	0.0155	CbGeAlD
Eletriptan—CYP2C9—endocrine gland—breast cancer	5.49e-05	0.0147	CbGeAlD
Eletriptan—PTGS1—female gonad—breast cancer	5.39e-05	0.0145	CbGeAlD
Eletriptan—PTGS1—endocrine gland—breast cancer	5.02e-05	0.0134	CbGeAlD
Eletriptan—CYP3A4—female reproductive system—breast cancer	4.95e-05	0.0133	CbGeAlD
Eletriptan—CYP2D6—female reproductive system—breast cancer	4.87e-05	0.0131	CbGeAlD
Eletriptan—ABCB1—epithelium—breast cancer	4.72e-05	0.0126	CbGeAlD
Eletriptan—CYP2D6—female gonad—breast cancer	4.43e-05	0.0119	CbGeAlD
Eletriptan—ABCB1—endometrium—breast cancer	4.23e-05	0.0113	CbGeAlD
Eletriptan—CYP3A4—endocrine gland—breast cancer	4.19e-05	0.0112	CbGeAlD
Eletriptan—CYP2D6—endocrine gland—breast cancer	4.12e-05	0.011	CbGeAlD
Eletriptan—ABCB1—uterus—breast cancer	3.9e-05	0.0104	CbGeAlD
Eletriptan—ABCB1—pituitary gland—breast cancer	3.83e-05	0.0103	CbGeAlD
Eletriptan—ABCB1—adipose tissue—breast cancer	3.81e-05	0.0102	CbGeAlD
Eletriptan—ABCB1—female reproductive system—breast cancer	3.5e-05	0.00939	CbGeAlD
Eletriptan—PTGS1—lymph node—breast cancer	3.47e-05	0.00929	CbGeAlD
Eletriptan—ABCB1—adrenal gland—breast cancer	3.42e-05	0.00916	CbGeAlD
Eletriptan—ABCB1—bone marrow—breast cancer	3.31e-05	0.00887	CbGeAlD
Eletriptan—ABCB1—female gonad—breast cancer	3.19e-05	0.00855	CbGeAlD
Eletriptan—ABCB1—endocrine gland—breast cancer	2.97e-05	0.00795	CbGeAlD
Eletriptan—Bradycardia—Doxorubicin—breast cancer	2.86e-05	0.000169	CcSEcCtD
Eletriptan—Dyspnoea—Docetaxel—breast cancer	2.85e-05	0.000169	CcSEcCtD
Eletriptan—Somnolence—Docetaxel—breast cancer	2.84e-05	0.000168	CcSEcCtD
Eletriptan—Rash—Gemcitabine—breast cancer	2.84e-05	0.000168	CcSEcCtD
Eletriptan—Dermatitis—Gemcitabine—breast cancer	2.84e-05	0.000168	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—breast cancer	2.83e-05	0.000167	CcSEcCtD
Eletriptan—Headache—Gemcitabine—breast cancer	2.82e-05	0.000167	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Capecitabine—breast cancer	2.82e-05	0.000167	CcSEcCtD
Eletriptan—Flushing—Epirubicin—breast cancer	2.82e-05	0.000167	CcSEcCtD
Eletriptan—Vomiting—Fluorouracil—breast cancer	2.82e-05	0.000167	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—breast cancer	2.82e-05	0.000166	CcSEcCtD
Eletriptan—Dyspepsia—Docetaxel—breast cancer	2.82e-05	0.000166	CcSEcCtD
Eletriptan—Insomnia—Capecitabine—breast cancer	2.8e-05	0.000166	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—breast cancer	2.8e-05	0.000165	CcSEcCtD
Eletriptan—Rash—Fluorouracil—breast cancer	2.79e-05	0.000165	CcSEcCtD
Eletriptan—Dermatitis—Fluorouracil—breast cancer	2.79e-05	0.000165	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—breast cancer	2.79e-05	0.000165	CcSEcCtD
Eletriptan—Paraesthesia—Capecitabine—breast cancer	2.78e-05	0.000164	CcSEcCtD
Eletriptan—Decreased appetite—Docetaxel—breast cancer	2.78e-05	0.000164	CcSEcCtD
Eletriptan—Hypersensitivity—Paclitaxel—breast cancer	2.78e-05	0.000164	CcSEcCtD
Eletriptan—Headache—Fluorouracil—breast cancer	2.78e-05	0.000164	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—breast cancer	2.77e-05	0.000164	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—breast cancer	2.77e-05	0.000164	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—breast cancer	2.77e-05	0.000163	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Docetaxel—breast cancer	2.76e-05	0.000163	CcSEcCtD
Eletriptan—Dyspnoea—Capecitabine—breast cancer	2.76e-05	0.000163	CcSEcCtD
Eletriptan—Fatigue—Docetaxel—breast cancer	2.76e-05	0.000163	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—breast cancer	2.75e-05	0.000163	CcSEcCtD
Eletriptan—Nausea—Mitoxantrone—breast cancer	2.75e-05	0.000162	CcSEcCtD
Eletriptan—Nausea—Irinotecan—breast cancer	2.75e-05	0.000162	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—breast cancer	2.74e-05	0.000162	CcSEcCtD
Eletriptan—Constipation—Docetaxel—breast cancer	2.74e-05	0.000162	CcSEcCtD
Eletriptan—Pain—Docetaxel—breast cancer	2.74e-05	0.000162	CcSEcCtD
Eletriptan—Back pain—Methotrexate—breast cancer	2.73e-05	0.000161	CcSEcCtD
Eletriptan—Dyspepsia—Capecitabine—breast cancer	2.73e-05	0.000161	CcSEcCtD
Eletriptan—Chills—Epirubicin—breast cancer	2.72e-05	0.000161	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—breast cancer	2.71e-05	0.00016	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—breast cancer	2.71e-05	0.00016	CcSEcCtD
Eletriptan—Asthenia—Paclitaxel—breast cancer	2.71e-05	0.00016	CcSEcCtD
Eletriptan—Decreased appetite—Capecitabine—breast cancer	2.69e-05	0.000159	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—breast cancer	2.68e-05	0.000159	CcSEcCtD
Eletriptan—Nausea—Gemcitabine—breast cancer	2.68e-05	0.000158	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Capecitabine—breast cancer	2.67e-05	0.000158	CcSEcCtD
Eletriptan—Fatigue—Capecitabine—breast cancer	2.67e-05	0.000158	CcSEcCtD
Eletriptan—Pruritus—Paclitaxel—breast cancer	2.67e-05	0.000158	CcSEcCtD
Eletriptan—Pain—Capecitabine—breast cancer	2.65e-05	0.000156	CcSEcCtD
Eletriptan—Constipation—Capecitabine—breast cancer	2.65e-05	0.000156	CcSEcCtD
Eletriptan—Feeling abnormal—Docetaxel—breast cancer	2.64e-05	0.000156	CcSEcCtD
Eletriptan—Nausea—Fluorouracil—breast cancer	2.63e-05	0.000156	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—breast cancer	2.62e-05	0.000155	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—breast cancer	2.62e-05	0.000155	CcSEcCtD
Eletriptan—Gastrointestinal pain—Docetaxel—breast cancer	2.62e-05	0.000155	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—breast cancer	2.61e-05	0.000154	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—breast cancer	2.61e-05	0.000154	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—breast cancer	2.6e-05	0.000154	CcSEcCtD
Eletriptan—Tension—Epirubicin—breast cancer	2.59e-05	0.000153	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—breast cancer	2.59e-05	0.000153	CcSEcCtD
Eletriptan—Diarrhoea—Paclitaxel—breast cancer	2.58e-05	0.000153	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—breast cancer	2.57e-05	0.000152	CcSEcCtD
Eletriptan—Back pain—Epirubicin—breast cancer	2.56e-05	0.000151	CcSEcCtD
Eletriptan—Feeling abnormal—Capecitabine—breast cancer	2.55e-05	0.000151	CcSEcCtD
Eletriptan—Malaise—Methotrexate—breast cancer	2.55e-05	0.000151	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—breast cancer	2.54e-05	0.00015	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—breast cancer	2.54e-05	0.00015	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—breast cancer	2.54e-05	0.00015	CcSEcCtD
Eletriptan—Gastrointestinal pain—Capecitabine—breast cancer	2.53e-05	0.00015	CcSEcCtD
Eletriptan—Abdominal pain—Docetaxel—breast cancer	2.53e-05	0.000149	CcSEcCtD
Eletriptan—Body temperature increased—Docetaxel—breast cancer	2.53e-05	0.000149	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—breast cancer	2.53e-05	0.000149	CcSEcCtD
Eletriptan—Chills—Doxorubicin—breast cancer	2.52e-05	0.000149	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—breast cancer	2.51e-05	0.000148	CcSEcCtD
Eletriptan—Dizziness—Paclitaxel—breast cancer	2.5e-05	0.000147	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—breast cancer	2.48e-05	0.000147	CcSEcCtD
Eletriptan—Cough—Methotrexate—breast cancer	2.46e-05	0.000146	CcSEcCtD
Eletriptan—Urticaria—Capecitabine—breast cancer	2.46e-05	0.000145	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—breast cancer	2.45e-05	0.000145	CcSEcCtD
Eletriptan—Body temperature increased—Capecitabine—breast cancer	2.45e-05	0.000145	CcSEcCtD
Eletriptan—Abdominal pain—Capecitabine—breast cancer	2.45e-05	0.000145	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—breast cancer	2.45e-05	0.000145	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—breast cancer	2.44e-05	0.000144	CcSEcCtD
Eletriptan—Agitation—Epirubicin—breast cancer	2.43e-05	0.000144	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—breast cancer	2.41e-05	0.000142	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—breast cancer	2.4e-05	0.000142	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—breast cancer	2.4e-05	0.000142	CcSEcCtD
Eletriptan—Tension—Doxorubicin—breast cancer	2.4e-05	0.000142	CcSEcCtD
Eletriptan—Vomiting—Paclitaxel—breast cancer	2.4e-05	0.000142	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—breast cancer	2.4e-05	0.000142	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.39e-05	0.000141	CcSEcCtD
Eletriptan—Malaise—Epirubicin—breast cancer	2.38e-05	0.000141	CcSEcCtD
Eletriptan—Rash—Paclitaxel—breast cancer	2.38e-05	0.000141	CcSEcCtD
Eletriptan—Dermatitis—Paclitaxel—breast cancer	2.38e-05	0.00014	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—breast cancer	2.38e-05	0.00014	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—breast cancer	2.38e-05	0.00014	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—breast cancer	2.37e-05	0.00014	CcSEcCtD
Eletriptan—Syncope—Epirubicin—breast cancer	2.37e-05	0.00014	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—breast cancer	2.37e-05	0.00014	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—breast cancer	2.37e-05	0.00014	CcSEcCtD
Eletriptan—Headache—Paclitaxel—breast cancer	2.36e-05	0.00014	CcSEcCtD
Eletriptan—Hypersensitivity—Docetaxel—breast cancer	2.36e-05	0.000139	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—breast cancer	2.35e-05	0.000139	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—breast cancer	2.34e-05	0.000138	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—breast cancer	2.32e-05	0.000137	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—breast cancer	2.32e-05	0.000137	CcSEcCtD
Eletriptan—Cough—Epirubicin—breast cancer	2.31e-05	0.000136	CcSEcCtD
Eletriptan—Asthenia—Docetaxel—breast cancer	2.29e-05	0.000136	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—breast cancer	2.29e-05	0.000135	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—breast cancer	2.28e-05	0.000135	CcSEcCtD
Eletriptan—Hypersensitivity—Capecitabine—breast cancer	2.28e-05	0.000135	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—breast cancer	2.27e-05	0.000134	CcSEcCtD
Eletriptan—Pruritus—Docetaxel—breast cancer	2.26e-05	0.000134	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—breast cancer	2.26e-05	0.000134	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—breast cancer	2.26e-05	0.000134	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—breast cancer	2.25e-05	0.000133	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—breast cancer	2.25e-05	0.000133	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—breast cancer	2.25e-05	0.000133	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—breast cancer	2.24e-05	0.000133	CcSEcCtD
Eletriptan—Nausea—Paclitaxel—breast cancer	2.24e-05	0.000132	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—breast cancer	2.24e-05	0.000132	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.24e-05	0.000132	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—breast cancer	2.23e-05	0.000132	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—breast cancer	2.22e-05	0.000131	CcSEcCtD
Eletriptan—Asthenia—Capecitabine—breast cancer	2.22e-05	0.000131	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—breast cancer	2.21e-05	0.00013	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—breast cancer	2.2e-05	0.00013	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—breast cancer	2.2e-05	0.00013	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—breast cancer	2.2e-05	0.00013	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—breast cancer	2.19e-05	0.00013	CcSEcCtD
Eletriptan—Pruritus—Capecitabine—breast cancer	2.19e-05	0.000129	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—breast cancer	2.19e-05	0.000129	CcSEcCtD
Eletriptan—Diarrhoea—Docetaxel—breast cancer	2.19e-05	0.000129	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—breast cancer	2.18e-05	0.000129	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—breast cancer	2.16e-05	0.000128	CcSEcCtD
Eletriptan—Oedema—Epirubicin—breast cancer	2.16e-05	0.000127	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—breast cancer	2.15e-05	0.000127	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—breast cancer	2.15e-05	0.000127	CcSEcCtD
Eletriptan—Cough—Doxorubicin—breast cancer	2.13e-05	0.000126	CcSEcCtD
Eletriptan—Shock—Epirubicin—breast cancer	2.12e-05	0.000125	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—breast cancer	2.12e-05	0.000125	CcSEcCtD
Eletriptan—Diarrhoea—Capecitabine—breast cancer	2.12e-05	0.000125	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—breast cancer	2.12e-05	0.000125	CcSEcCtD
Eletriptan—Dizziness—Docetaxel—breast cancer	2.12e-05	0.000125	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—breast cancer	2.11e-05	0.000125	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—breast cancer	2.11e-05	0.000124	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—breast cancer	2.1e-05	0.000124	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—breast cancer	2.1e-05	0.000124	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—breast cancer	2.09e-05	0.000123	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—breast cancer	2.09e-05	0.000123	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—breast cancer	2.08e-05	0.000123	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—breast cancer	2.08e-05	0.000123	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—breast cancer	2.08e-05	0.000123	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—breast cancer	2.07e-05	0.000122	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.07e-05	0.000122	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—breast cancer	2.06e-05	0.000122	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—breast cancer	2.06e-05	0.000122	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—breast cancer	2.06e-05	0.000121	CcSEcCtD
Eletriptan—ABCB1—lymph node—breast cancer	2.05e-05	0.00549	CbGeAlD
Eletriptan—Somnolence—Methotrexate—breast cancer	2.05e-05	0.000121	CcSEcCtD
Eletriptan—Dizziness—Capecitabine—breast cancer	2.05e-05	0.000121	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—breast cancer	2.04e-05	0.00012	CcSEcCtD
Eletriptan—Vomiting—Docetaxel—breast cancer	2.03e-05	0.00012	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—breast cancer	2.03e-05	0.00012	CcSEcCtD
Eletriptan—Rash—Docetaxel—breast cancer	2.02e-05	0.000119	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—breast cancer	2.02e-05	0.000119	CcSEcCtD
Eletriptan—Dermatitis—Docetaxel—breast cancer	2.01e-05	0.000119	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—breast cancer	2.01e-05	0.000119	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—breast cancer	2e-05	0.000118	CcSEcCtD
Eletriptan—Headache—Docetaxel—breast cancer	2e-05	0.000118	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—breast cancer	2e-05	0.000118	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—breast cancer	1.99e-05	0.000118	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—breast cancer	1.99e-05	0.000117	CcSEcCtD
Eletriptan—Pain—Methotrexate—breast cancer	1.97e-05	0.000116	CcSEcCtD
Eletriptan—Vomiting—Capecitabine—breast cancer	1.97e-05	0.000116	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—breast cancer	1.97e-05	0.000116	CcSEcCtD
Eletriptan—Shock—Doxorubicin—breast cancer	1.96e-05	0.000116	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—breast cancer	1.96e-05	0.000116	CcSEcCtD
Eletriptan—Rash—Capecitabine—breast cancer	1.95e-05	0.000115	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—breast cancer	1.95e-05	0.000115	CcSEcCtD
Eletriptan—Dermatitis—Capecitabine—breast cancer	1.95e-05	0.000115	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—breast cancer	1.95e-05	0.000115	CcSEcCtD
Eletriptan—Headache—Capecitabine—breast cancer	1.94e-05	0.000115	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—breast cancer	1.94e-05	0.000115	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—breast cancer	1.94e-05	0.000114	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—breast cancer	1.93e-05	0.000114	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—breast cancer	1.92e-05	0.000114	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—breast cancer	1.92e-05	0.000113	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—breast cancer	1.9e-05	0.000112	CcSEcCtD
Eletriptan—Nausea—Docetaxel—breast cancer	1.9e-05	0.000112	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—breast cancer	1.9e-05	0.000112	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—breast cancer	1.9e-05	0.000112	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—breast cancer	1.89e-05	0.000111	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—breast cancer	1.88e-05	0.000111	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—breast cancer	1.87e-05	0.00011	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—breast cancer	1.86e-05	0.00011	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—breast cancer	1.86e-05	0.00011	CcSEcCtD
Eletriptan—Constipation—Epirubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Eletriptan—Pain—Epirubicin—breast cancer	1.84e-05	0.000109	CcSEcCtD
Eletriptan—Nausea—Capecitabine—breast cancer	1.84e-05	0.000109	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—breast cancer	1.83e-05	0.000108	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—breast cancer	1.82e-05	0.000108	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—breast cancer	1.82e-05	0.000108	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.82e-05	0.000107	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—breast cancer	1.81e-05	0.000107	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—breast cancer	1.79e-05	0.000106	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—breast cancer	1.78e-05	0.000105	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—breast cancer	1.78e-05	0.000105	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—breast cancer	1.77e-05	0.000105	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—breast cancer	1.76e-05	0.000104	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—breast cancer	1.76e-05	0.000104	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—breast cancer	1.74e-05	0.000103	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—breast cancer	1.72e-05	0.000102	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—breast cancer	1.72e-05	0.000102	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Eletriptan—Pain—Doxorubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—breast cancer	1.71e-05	0.000101	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—breast cancer	1.7e-05	0.0001	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—breast cancer	1.65e-05	9.77e-05	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—breast cancer	1.64e-05	9.72e-05	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—breast cancer	1.63e-05	9.65e-05	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—breast cancer	1.63e-05	9.64e-05	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—breast cancer	1.59e-05	9.39e-05	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—breast cancer	1.59e-05	9.37e-05	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—breast cancer	1.58e-05	9.33e-05	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—breast cancer	1.58e-05	9.33e-05	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—breast cancer	1.58e-05	9.32e-05	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—breast cancer	1.55e-05	9.15e-05	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—breast cancer	1.53e-05	9.02e-05	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—breast cancer	1.52e-05	9.01e-05	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—breast cancer	1.48e-05	8.72e-05	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—breast cancer	1.47e-05	8.69e-05	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—breast cancer	1.47e-05	8.66e-05	CcSEcCtD
Eletriptan—Rash—Methotrexate—breast cancer	1.45e-05	8.59e-05	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—breast cancer	1.45e-05	8.58e-05	CcSEcCtD
Eletriptan—Headache—Methotrexate—breast cancer	1.44e-05	8.53e-05	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—breast cancer	1.43e-05	8.46e-05	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—breast cancer	1.43e-05	8.43e-05	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—breast cancer	1.41e-05	8.35e-05	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—breast cancer	1.37e-05	8.11e-05	CcSEcCtD
Eletriptan—Nausea—Methotrexate—breast cancer	1.37e-05	8.09e-05	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—breast cancer	1.37e-05	8.07e-05	CcSEcCtD
Eletriptan—Rash—Epirubicin—breast cancer	1.36e-05	8.04e-05	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—breast cancer	1.36e-05	8.03e-05	CcSEcCtD
Eletriptan—Headache—Epirubicin—breast cancer	1.35e-05	7.99e-05	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—breast cancer	1.32e-05	7.8e-05	CcSEcCtD
Eletriptan—Nausea—Epirubicin—breast cancer	1.28e-05	7.57e-05	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—breast cancer	1.27e-05	7.5e-05	CcSEcCtD
Eletriptan—Rash—Doxorubicin—breast cancer	1.26e-05	7.44e-05	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—breast cancer	1.26e-05	7.43e-05	CcSEcCtD
Eletriptan—Headache—Doxorubicin—breast cancer	1.25e-05	7.39e-05	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—breast cancer	1.19e-05	7.01e-05	CcSEcCtD
Eletriptan—CYP2C9—Metabolism—GSTP1—breast cancer	2.41e-06	3.07e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDKN1A—breast cancer	2.41e-06	3.07e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—breast cancer	2.41e-06	3.06e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1B—breast cancer	2.4e-06	3.06e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TYMS—breast cancer	2.4e-06	3.06e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—breast cancer	2.4e-06	3.05e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CB—breast cancer	2.4e-06	3.05e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ITPR1—breast cancer	2.39e-06	3.05e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CD—breast cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—breast cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—breast cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—breast cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ITPR1—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PLA2G4A—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NCOR1—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK8—breast cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HPGDS—breast cancer	2.37e-06	3.01e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—breast cancer	2.36e-06	3.01e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDKN1A—breast cancer	2.36e-06	3.01e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	2.36e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—breast cancer	2.36e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—breast cancer	2.36e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—breast cancer	2.35e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK8—breast cancer	2.35e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—breast cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HBA1—breast cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—breast cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—breast cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—breast cancer	2.34e-06	2.98e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—breast cancer	2.33e-06	2.97e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—breast cancer	2.33e-06	2.96e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—breast cancer	2.32e-06	2.95e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK8—breast cancer	2.3e-06	2.93e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP1A1—breast cancer	2.3e-06	2.93e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—breast cancer	2.3e-06	2.93e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—breast cancer	2.3e-06	2.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—breast cancer	2.29e-06	2.92e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ACHE—breast cancer	2.29e-06	2.92e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—breast cancer	2.29e-06	2.92e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—JUN—breast cancer	2.29e-06	2.91e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ERCC2—breast cancer	2.28e-06	2.91e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—breast cancer	2.28e-06	2.91e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—breast cancer	2.27e-06	2.89e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—breast cancer	2.27e-06	2.89e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CB—breast cancer	2.27e-06	2.89e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TYMS—breast cancer	2.26e-06	2.88e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—breast cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP1A1—breast cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—breast cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SRC—breast cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TYMS—breast cancer	2.24e-06	2.85e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NCOR1—breast cancer	2.23e-06	2.85e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.23e-06	2.85e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—breast cancer	2.23e-06	2.85e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SRC—breast cancer	2.23e-06	2.84e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ERCC2—breast cancer	2.23e-06	2.84e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—breast cancer	2.23e-06	2.83e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1A—breast cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—breast cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—breast cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NCOR1—breast cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—breast cancer	2.21e-06	2.82e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—breast cancer	2.19e-06	2.78e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SRC—breast cancer	2.18e-06	2.78e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—breast cancer	2.17e-06	2.77e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP17A1—breast cancer	2.17e-06	2.77e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—breast cancer	2.17e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—breast cancer	2.17e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK8—breast cancer	2.16e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—breast cancer	2.16e-06	2.75e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—breast cancer	2.15e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS1—breast cancer	2.15e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO1—breast cancer	2.15e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—breast cancer	2.15e-06	2.73e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—breast cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MDM2—breast cancer	2.13e-06	2.72e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—breast cancer	2.13e-06	2.71e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAF1—breast cancer	2.13e-06	2.71e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—breast cancer	2.12e-06	2.7e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A1—breast cancer	2.12e-06	2.7e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—breast cancer	2.12e-06	2.7e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2D6—breast cancer	2.11e-06	2.68e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—breast cancer	2.11e-06	2.68e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—breast cancer	2.1e-06	2.68e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ERCC2—breast cancer	2.1e-06	2.68e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A1—breast cancer	2.1e-06	2.67e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—breast cancer	2.1e-06	2.67e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ERCC2—breast cancer	2.08e-06	2.65e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MTOR—breast cancer	2.08e-06	2.64e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CB—breast cancer	2.08e-06	2.64e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—breast cancer	2.07e-06	2.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NCOA2—breast cancer	2.07e-06	2.64e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK3—breast cancer	2.07e-06	2.63e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK3—breast cancer	2.06e-06	2.62e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SRC—breast cancer	2.05e-06	2.61e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—breast cancer	2.04e-06	2.6e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK3—breast cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—breast cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—breast cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—FASN—breast cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—breast cancer	2e-06	2.55e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—breast cancer	2e-06	2.55e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—breast cancer	2e-06	2.54e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—breast cancer	2e-06	2.54e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—breast cancer	1.99e-06	2.54e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAV1—breast cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—breast cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—breast cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC5A5—breast cancer	1.97e-06	2.51e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—breast cancer	1.97e-06	2.51e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—breast cancer	1.96e-06	2.5e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—breast cancer	1.96e-06	2.49e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—breast cancer	1.96e-06	2.49e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—breast cancer	1.95e-06	2.49e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.95e-06	2.49e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.95e-06	2.48e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAV1—breast cancer	1.93e-06	2.46e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.93e-06	2.45e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—breast cancer	1.91e-06	2.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—breast cancer	1.91e-06	2.43e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—breast cancer	1.91e-06	2.43e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NQO1—breast cancer	1.91e-06	2.43e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A1—breast cancer	1.91e-06	2.43e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—breast cancer	1.9e-06	2.42e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.89e-06	2.41e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK3—breast cancer	1.89e-06	2.41e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—breast cancer	1.86e-06	2.37e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—breast cancer	1.86e-06	2.37e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—JUN—breast cancer	1.85e-06	2.36e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—breast cancer	1.85e-06	2.35e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.84e-06	2.34e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—breast cancer	1.84e-06	2.34e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—breast cancer	1.83e-06	2.34e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1B1—breast cancer	1.83e-06	2.33e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAV1—breast cancer	1.82e-06	2.32e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—breast cancer	1.81e-06	2.3e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAV1—breast cancer	1.81e-06	2.3e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—breast cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CG—breast cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—breast cancer	1.8e-06	2.29e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.8e-06	2.29e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—breast cancer	1.79e-06	2.28e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.79e-06	2.28e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CG—breast cancer	1.76e-06	2.24e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.75e-06	2.24e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.75e-06	2.23e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NCOA1—breast cancer	1.74e-06	2.22e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.73e-06	2.2e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—STK11—breast cancer	1.72e-06	2.19e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP19A1—breast cancer	1.72e-06	2.19e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—breast cancer	1.71e-06	2.18e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—breast cancer	1.7e-06	2.16e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—breast cancer	1.7e-06	2.16e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SRC—breast cancer	1.66e-06	2.12e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.66e-06	2.12e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CG—breast cancer	1.66e-06	2.11e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—breast cancer	1.65e-06	2.1e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CG—breast cancer	1.65e-06	2.1e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—breast cancer	1.64e-06	2.09e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.62e-06	2.06e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—breast cancer	1.61e-06	2.05e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—breast cancer	1.6e-06	2.04e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—COMT—breast cancer	1.6e-06	2.03e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—breast cancer	1.59e-06	2.03e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CD—breast cancer	1.59e-06	2.02e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—breast cancer	1.58e-06	2.01e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—breast cancer	1.57e-06	2e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—breast cancer	1.57e-06	2e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—breast cancer	1.57e-06	1.99e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ITPR1—breast cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CD—breast cancer	1.55e-06	1.97e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—breast cancer	1.54e-06	1.96e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.53e-06	1.95e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—breast cancer	1.53e-06	1.95e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—breast cancer	1.51e-06	1.93e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—breast cancer	1.51e-06	1.92e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—breast cancer	1.51e-06	1.92e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—breast cancer	1.5e-06	1.91e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—breast cancer	1.5e-06	1.91e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—breast cancer	1.49e-06	1.9e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.49e-06	1.89e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TYMS—breast cancer	1.48e-06	1.88e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—breast cancer	1.47e-06	1.87e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NCOR1—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CD—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—breast cancer	1.46e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CD—breast cancer	1.45e-06	1.84e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—breast cancer	1.44e-06	1.84e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—breast cancer	1.44e-06	1.83e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—breast cancer	1.43e-06	1.82e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—breast cancer	1.4e-06	1.78e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—breast cancer	1.4e-06	1.78e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—breast cancer	1.39e-06	1.77e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A1—breast cancer	1.39e-06	1.76e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CB—breast cancer	1.38e-06	1.76e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—breast cancer	1.38e-06	1.76e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—breast cancer	1.38e-06	1.76e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—breast cancer	1.38e-06	1.75e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—breast cancer	1.38e-06	1.75e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ERCC2—breast cancer	1.37e-06	1.75e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—breast cancer	1.37e-06	1.74e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—breast cancer	1.37e-06	1.74e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—breast cancer	1.36e-06	1.73e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CB—breast cancer	1.35e-06	1.72e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—breast cancer	1.34e-06	1.7e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—breast cancer	1.29e-06	1.64e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—breast cancer	1.27e-06	1.62e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CB—breast cancer	1.27e-06	1.62e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.27e-06	1.61e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CB—breast cancer	1.26e-06	1.61e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—breast cancer	1.26e-06	1.6e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—breast cancer	1.25e-06	1.59e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—breast cancer	1.22e-06	1.56e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—breast cancer	1.19e-06	1.52e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—breast cancer	1.19e-06	1.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAV1—breast cancer	1.19e-06	1.52e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—breast cancer	1.17e-06	1.49e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—breast cancer	1.17e-06	1.49e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—breast cancer	1.13e-06	1.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—breast cancer	1.12e-06	1.43e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—breast cancer	1.1e-06	1.4e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—breast cancer	1.09e-06	1.39e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CG—breast cancer	1.09e-06	1.38e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—breast cancer	1.03e-06	1.32e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CD—breast cancer	9.54e-07	1.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—breast cancer	9.42e-07	1.2e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—breast cancer	9.01e-07	1.15e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—breast cancer	8.43e-07	1.07e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CB—breast cancer	8.31e-07	1.06e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—breast cancer	8.24e-07	1.05e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—breast cancer	8.23e-07	1.05e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—breast cancer	7.75e-07	9.87e-06	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—breast cancer	7.68e-07	9.79e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—breast cancer	7.18e-07	9.15e-06	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—breast cancer	6.89e-07	8.77e-06	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—breast cancer	6.72e-07	8.56e-06	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—breast cancer	6.33e-07	8.06e-06	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—breast cancer	6.28e-07	8e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—breast cancer	5.07e-07	6.45e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—breast cancer	4.14e-07	5.27e-06	CbGpPWpGaD
